Literature DB >> 8399888

Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin.

W W Yew, C F Wong, P C Wong, J Lee, C H Chau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8399888     DOI： 10.1093/clinids/17.2.288

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  17 in total

1.  Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth.

Authors:  Ofelia Chacon; Zhengyu Feng; N Beth Harris; Nancy E Cáceres; L Garry Adams; Raúl G Barletta
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 2.  Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions.

Authors:  Kari A Mergenhagen; Bethany A Wattengel; Megan K Skelly; Collin M Clark; Thomas A Russo
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

3.  Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine.

Authors:  Tathyana Mar Amorim Franco; Lorenza Favrot; Olivia Vergnolle; John S Blanchard
Journal:  ACS Chem Biol       Date:  2017-03-16       Impact factor: 5.100

Review 4.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  The role of fluoroquinolones in tuberculosis today.

Authors:  S E Berning
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis.

Authors:  N E Cáceres; N B Harris; J F Wellehan; Z Feng; V Kapur; R G Barletta
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

7.  Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones.

Authors:  Yashang Lee; Sara Mootien; Carolyn Shoen; Michelle Destefano; Pier Cirillo; Oluwatoyin A Asojo; Kacheong R Yeung; Michel Ledizet; Michael H Cynamon; Paul A Aristoff; Raymond A Koski; Paul A Kaplan; Karen G Anthony
Journal:  Biochem Pharmacol       Date:  2013-05-13       Impact factor: 5.858

8.  Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine.

Authors:  Zhengyu Feng; Raúl G Barletta
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 9.  Tuberculosis in the AIDS era.

Authors:  K A Sepkowitz; J Raffalli; L Riley; T E Kiehn; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

10.  New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis.

Authors:  Karen G Anthony; Ulrich Strych; Kacheong R Yeung; Carolyn S Shoen; Oriana Perez; Kurt L Krause; Michael H Cynamon; Paul A Aristoff; Raymond A Koski
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.